BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15214437)

  • 1. Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins.
    Lejon T; Stiberg T; Strøm MB; Svendsen JS
    J Pept Sci; 2004 Jun; 10(6):329-35. PubMed ID: 15214437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple parameterization of non-proteinogenic amino acids for QSAR of antibacterial peptides.
    Lejon T; Svendsen JS; Haug BE
    J Pept Sci; 2002 Jul; 8(7):302-6. PubMed ID: 12148779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic activity of pentadecapeptides modelled from amino acid descriptors.
    Lejon T; Strøm MB; Svendsen JS
    J Pept Sci; 2001 Feb; 7(2):74-81. PubMed ID: 11277499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc).
    Haug BE; Andersen J; Rekdal O; Svendsen JS
    J Pept Sci; 2002 Jul; 8(7):307-13. PubMed ID: 12148780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.
    Strøm MB; Rekdal O; Svendsen JS
    J Pept Sci; 2002 Jan; 8(1):36-43. PubMed ID: 11831560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stochastic-based descriptors studying biopolymers biological properties: extended MARCH-INSIDE methodology describing antibacterial activity of lactoferricin derivatives.
    de Armas RR; Díaz HG; Molina R; Uriarte E
    Biopolymers; 2005 Apr; 77(5):247-56. PubMed ID: 15682438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli.
    Flores-Villaseñor H; Canizalez-Román A; Reyes-Lopez M; Nazmi K; de la Garza M; Zazueta-Beltrán J; León-Sicairos N; Bolscher JG
    Biometals; 2010 Jun; 23(3):569-78. PubMed ID: 20195887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
    Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
    J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short linear cationic antimicrobial peptides: screening, optimizing, and prediction.
    Hilpert K; Fjell CD; Cherkasov A
    Methods Mol Biol; 2008; 494():127-59. PubMed ID: 18726572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
    Farnaud S; Patel A; Odell EW; Evans RW
    FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumour activity and specificity as a function of substitutions in the lipophilic sector of helical lactoferrin-derived peptide.
    Yang N; Lejon T; Rekdal O
    J Pept Sci; 2003 May; 9(5):300-11. PubMed ID: 12803496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide.
    Haug BE; Svendsen JS
    J Pept Sci; 2001 Apr; 7(4):190-6. PubMed ID: 11354462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli.
    Ulvatne H; Vorland LH
    Scand J Infect Dis; 2001; 33(7):507-11. PubMed ID: 11515760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin.
    Vorland LH; Ulvatne H; Andersen J; Haukland H; Rekdal O; Svendsen JS; Gutteberg TJ
    Scand J Infect Dis; 1998; 30(5):513-7. PubMed ID: 10066056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin.
    Nguyen LT; Schibli DJ; Vogel HJ
    J Pept Sci; 2005 Jul; 11(7):379-89. PubMed ID: 15635665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bulky aromatic amino acids increase the antibacterial activity of 15-residue bovine lactoferricin derivatives.
    Haug BE; Skar ML; Svendsen JS
    J Pept Sci; 2001 Aug; 7(8):425-32. PubMed ID: 11548058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of 15-residue lactoferricin derivatives.
    Strøm MB; Rekdal O; Svendsen JS
    J Pept Res; 2000 Nov; 56(5):265-74. PubMed ID: 11095180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homology similarity analysis of sequences of lactoferricin and its derivatives.
    Nakai S; Chan JC; Li-Chan EC; Dou J; Ogawa M
    J Agric Food Chem; 2003 Feb; 51(5):1215-23. PubMed ID: 12590458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity.
    Farnaud S; Spiller C; Moriarty LC; Patel A; Gant V; Odell EW; Evans RW
    FEMS Microbiol Lett; 2004 Apr; 233(2):193-9. PubMed ID: 15063486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of synthetic peptides derived from lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212.
    León-Calvijo MA; Leal-Castro AL; Almanzar-Reina GA; Rosas-Pérez JE; García-Castañeda JE; Rivera-Monroy ZJ
    Biomed Res Int; 2015; 2015():453826. PubMed ID: 25815317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.